Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 30, 2006

ReNeuron Inks Collaboration Agreement with CellSeed

  • ReNeuron and CellSeed signed a collaboration agreement to develop liver-cell culture systems for drug safety screening in the pharmaceutical industry.

    The development work, to be conducted in CellSeed’s laboratories in Tokyo, will establish protocols for developing ReNeuron’s ReNcell™ HEP hepatocyte cell-lines in combination with CellSeed’s UpCell and HydroCell temperature-sensitive polymer products for 3-D functional liver tissue.

    3-D liver culture systems represent a way to assay for human liver toxicity of new drugs. The collaboration will enable the joint development of human cell-based drug discovery products for use in the pharmaceutical industry.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.